Insider txns (12m)
25
Stock / equity
TXN TEXAS INSTRUMENTS INC
Company profile, contracts and lobbying: TEXAS INSTRUMENTS INC
TXN (TEXAS INSTRUMENTS INC) has 25 disclosed insider transactions from 8 insiders in the last 12 months (0 open-market buys, 10 sales, about $34.1M at reported prices) and 0 congressional trades from 0 members of Congress. The most recent disclosure was filed September 21, 2026.
Open-market buys / sales
0 / 10
Congress trades (12m)
0
Distinct filers (12m)
8
Insider transactions
| Filer | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source |
|---|---|---|---|---|---|---|---|---|---|
| PATSLEY PAMELA H | Other A | September 18, 2026 | September 21, 2026 | 3d | 107 | $258 | $27K | derivative | Form 4 ↗ |
| FARMER CURTIS C | Other A | September 18, 2026 | September 21, 2026 | 3d | 107 | $258 | $27K | derivative | Form 4 ↗ |
| Abraham Tsedeniya | Option / conversion M | August 27, 2026 | August 31, 2026 | 4d | 1,365 | — | — | derivative | Form 4 ↗ |
| Abraham Tsedeniya | Sell S | August 27, 2026 | August 31, 2026 | 4d | 592 | $265 | $157K | Form 4 ↗ | |
| Abraham Tsedeniya | Sell S | August 27, 2026 | August 31, 2026 | 4d | 6,408 | $265 | $1.7M | Form 4 ↗ | |
| Abraham Tsedeniya | Option / conversion M | August 27, 2026 | August 31, 2026 | 4d | 1,365 | $79 | $108K | Form 4 ↗ | |
| Knecht Julie C. | Other A | July 24, 2026 | July 31, 2026 | 7d | 7,154 | — | — | late | Form 4 ↗ |
| PATSLEY PAMELA H | Other A | June 19, 2026 | June 22, 2026 | 3d | 85 | $323 | $28K | derivative | Form 4 ↗ |
| FARMER CURTIS C | Other A | June 19, 2026 | June 22, 2026 | 3d | 85 | $323 | $28K | derivative | Form 4 ↗ |
| Craighead Martin S | Sell S | May 28, 2026 | May 29, 2026 | 1d | 357 | $321 | $115K | Form 4 ↗ | |
| Craighead Martin S | Sell S | May 28, 2026 | May 29, 2026 | 1d | 9,643 | $320 | $3.1M | Form 4 ↗ | |
| Lizardi Rafael R | Option / conversion M | May 14, 2026 | May 15, 2026 | 1d | 47,734 | — | — | derivative | Form 4 ↗ |
| Lizardi Rafael R | Sell S | May 14, 2026 | May 15, 2026 | 1d | 1,459 | $309 | $451K | Form 4 ↗ | |
| Lizardi Rafael R | Sell S | May 14, 2026 | May 15, 2026 | 1d | 14,156 | $309 | $4.4M | Form 4 ↗ | |
| Lizardi Rafael R | Sell S | May 14, 2026 | May 15, 2026 | 1d | 32,119 | $308 | $9.9M | Form 4 ↗ | |
| Lizardi Rafael R | Option / conversion M | May 14, 2026 | May 15, 2026 | 1d | 47,734 | $175 | $8.3M | Form 4 ↗ | |
| BAHAI AHMAD | Option / conversion M | May 14, 2026 | May 15, 2026 | 1d | 5,000 | — | — | derivative | Form 4 ↗ |
| BAHAI AHMAD | Sell S | May 14, 2026 | May 15, 2026 | 1d | 5,000 | $309 | $1.5M | Form 4 ↗ | |
| BAHAI AHMAD | Option / conversion M | May 14, 2026 | May 15, 2026 | 1d | 5,000 | $110 | $551K | Form 4 ↗ | |
| COX CARRIE SMITH | Option / conversion M | May 13, 2026 | May 14, 2026 | 1d | 4,532 | — | — | derivative | Form 4 ↗ |
| COX CARRIE SMITH | Option / conversion M | May 13, 2026 | May 14, 2026 | 1d | 4,306 | — | — | derivative | Form 4 ↗ |
| COX CARRIE SMITH | Sell S | May 13, 2026 | May 14, 2026 | 1d | 445 | $307 | $137K | Form 4 ↗ | |
| COX CARRIE SMITH | Sell S | May 13, 2026 | May 14, 2026 | 1d | 8,393 | $306 | $2.6M | Form 4 ↗ | |
| COX CARRIE SMITH | Option / conversion M | May 13, 2026 | May 14, 2026 | 1d | 4,532 | $104 | $473K | Form 4 ↗ | |
| COX CARRIE SMITH | Option / conversion M | May 13, 2026 | May 14, 2026 | 1d | 4,306 | $110 | $474K | Form 4 ↗ |
Congressional trades
No member of Congress has disclosed a trade in this ticker in the filings we have parsed (House filings since the job went live; Senate pending).
Who is filing
- PATSLEY PAMELA H — 2 transactions
- FARMER CURTIS C — 2 transactions
- Abraham Tsedeniya — 4 transactions
- Knecht Julie C. — 1 transaction
- Craighead Martin S — 2 transactions
- Lizardi Rafael R — 5 transactions
- BAHAI AHMAD — 3 transactions
- COX CARRIE SMITH — 6 transactions
Sources and method
Insider rows are Form 4 filings for this issuer from SEC EDGAR; congressional rows are periodic transaction reports parsed from the House Clerk (and Senate eFD when live). Values use the reported price for Form 4 and the disclosed range for Congress. See methodology and corrections.
Not investment advice. Disclosures are shown as filed and may lag the trade or be amended. No recommendation is made or implied.